U.S. flag

An official website of the United States government

NM_000179.3(MSH6):c.3610G>A (p.Ala1204Thr) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 1, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001020725.3

Allele description [Variation Report for NM_000179.3(MSH6):c.3610G>A (p.Ala1204Thr)]

NM_000179.3(MSH6):c.3610G>A (p.Ala1204Thr)

Gene:
MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.3610G>A (p.Ala1204Thr)
HGVS:
  • NC_000002.12:g.47805671G>A
  • NG_007111.1:g.27525G>A
  • NG_008397.1:g.105005C>T
  • NM_000179.3:c.3610G>AMANE SELECT
  • NM_001281492.2:c.3220G>A
  • NM_001281493.2:c.2704G>A
  • NM_001281494.2:c.2704G>A
  • NP_000170.1:p.Ala1204Thr
  • NP_000170.1:p.Ala1204Thr
  • NP_001268421.1:p.Ala1074Thr
  • NP_001268422.1:p.Ala902Thr
  • NP_001268423.1:p.Ala902Thr
  • LRG_219t1:c.3610G>A
  • LRG_219:g.27525G>A
  • LRG_219p1:p.Ala1204Thr
  • NC_000002.11:g.48032810G>A
  • NM_000179.2:c.3610G>A
Protein change:
A1074T
Links:
dbSNP: rs869312799
NCBI 1000 Genomes Browser:
rs869312799
Molecular consequence:
  • NM_000179.3:c.3610G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281492.2:c.3220G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281493.2:c.2704G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281494.2:c.2704G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001182238Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Oct 1, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Improving performance of multigene panels for genomic analysis of cancer predisposition.

Shirts BH, Casadei S, Jacobson AL, Lee MK, Gulsuner S, Bennett RL, Miller M, Hall SA, Hampel H, Hisama FM, Naylor LV, Goetsch C, Leppig K, Tait JF, Scroggins SM, Turner EH, Livingston R, Salipante SJ, King MC, Walsh T, Pritchard CC.

Genet Med. 2016 Oct;18(10):974-81. doi: 10.1038/gim.2015.212. Epub 2016 Feb 4.

PubMed [citation]
PMID:
26845104

Details of each submission

From Ambry Genetics, SCV001182238.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

The p.A1204T variant (also known as c.3610G>A), located in coding exon 7 of the MSH6 gene, results from a G to A substitution at nucleotide position 3610. The alanine at codon 1204 is replaced by threonine, an amino acid with similar properties. This alteration was detected in an individual with fallopian tube cancer that had intact staining for the mismatch repair genes by immunohistochemistry (IHC) (Shirts BH et al. Genet Med, 2016 10;18:974-81). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024